Private EquityScreenerRefer

MARKET INSIGHTS

  • EventsNEWPrivate market milestones
  • NewsPrecize daily pulse
  • BlogsIn-depth articles and opinions

GUIDES

Explore Now
  • Unlisted SharesStep-by-step · KYC
  • BuyingStep-by-step · KYC
  • SellingExit in 24 - 48 hours
  • Pre-IPOReturns · risks · case studies
  • Tax GuideBudget 2026 changes
  1. Home
  2. Shares
  3. API Holdings (Pharmeasy)

API Holdings (Pharmeasy) Unlisted Share Price Today

ISIN INE0DJ201029.

API Holdings (Pharmeasy) has developed a healthcare delivery platform to simplify and modernize the healthcare setup in India. Data and technology are the driving factors behind a robust health and well-being ecosystem today, and API Holdings (Pharmeasy) is leveraging both to strengthen healthcare in India. Overview of API Holdings (Pharmeasy) Founded in 2012, API Holdings has established itself as a leader in India's digital healthcare sector. Operating under the brand name PharmEasy, it has…

API Holdings (Pharmeasy)

Login to view price
API Holdings (Pharmeasy)

API Holdings (Pharmeasy) Unlisted Share Price Today

Price
Login to view
Loading chart data...
SectorHealthcare & Pharmaceuticals
ISININE0DJ201029
Depository
Market Cap₹9,977.08 Cr
P/E Ratio-6.19
ROE (%)-15.53
Revenue₹6,618.5 Cr
Book Value2.23
Debt to Equity0.38
Face Value1
52W High₹521
52W Low₹5.05
Market Cap₹9,977.08 Cr
P/E Ratio-6.19
ROE (%)-15.53
Revenue₹6,618.5 Cr
Book Value2.23
Debt to Equity0.38
52W High/Low₹521 / ₹5.05
Face Value1
As of FY26

About the company & Industry

Overview of API Holdings (Pharmeasy)

Founded in 2012, API Holdings has established itself as a leader in India's digital healthcare sector. Operating under the brand name PharmEasy, it has grown to become the country’s largest digital healthcare platform, as measured by the GMV of products and services sold as of March 31, 2021. Headquartered in Ghatkopar West, Mumbai, the company offers an integrated, end-to-end solution designed to meet the healthcare needs of a wide range of consumers. API Holdings provides services to diverse stakeholders, including consumers, pharmaceutical companies, wholesalers, pharmacies, hospitals, doctors, clinics, and diagnostic labs, creating a seamless and connected healthcare ecosystem throughout India.

Overview of API Holdings (Pharmeasy)

Founded in 2012, API Holdings has established itself as a leader in India's digital healthcare sector. Operating under the brand name PharmEasy, it has grown to become the country’s largest digital healthcare platform, as measured by the GMV of products and services sold as of March 31, 2021. Headquartered in Ghatkopar West, Mumbai, the company offers an integrated, end-to-end solution designed to meet the healthcare needs of a wide range of consumers. API Holdings provides services to diverse stakeholders, including consumers, pharmaceutical companies, wholesalers, pharmacies, hospitals, doctors, clinics, and diagnostic labs, creating a seamless and connected healthcare ecosystem throughout India.

Financials

Revenue Recovered Strongly

Revenue from operations grew 12.71% in FY26 to ₹6,619 Cr, following 3.67% growth in FY25.

EBITDA Turned Positive

After reporting negative EBITDA every year since FY21, the company generated ₹110 Cr EBITDA in FY26, with EBITDA margin turning positive at 1.66%.

Losses Narrowed Significantly

PAT loss narrowed from ₹5,212 Cr in FY23 to ₹520 Cr in FY26, while EPS improved from -₹8.51 to -₹0.37, indicating a substantial reduction in losses.

Income Statement

Revenue(Figures in Cr.)

Revenue Recovered Strongly

Revenue from operations grew 12.71% in FY26 to ₹6,619 Cr, following 3.67% growth in FY25.

EBITDA Turned Positive

After reporting negative EBITDA every year since FY21, the company generated ₹110 Cr EBITDA in FY26, with EBITDA margin turning positive at 1.66%.

Losses Narrowed Significantly

PAT loss narrowed from ₹5,212 Cr in FY23 to ₹520 Cr in FY26, while EPS improved from -₹8.51 to -₹0.37, indicating a substantial reduction in losses.

Income Statement

Revenue(Figures in Cr.)

Management

Shareholding PatternAs of FY26
Naspers Ventures B. V
11.58%
MacRitchie Investments Pte. Ltd
10.43%
TPG Growth V SF Markets Pte. Ltd
6.40%
Dr. Velumani A
5.70%
Evermed Holdings Pte. Ltd
5.64%
Others
60.25%

Key Managerial Personnel

As of FY26
NameDesignation and Experience
Dr. Dhaval Shah
Co-Founder
Siddharth Shah
Chief Executive Officer

Shareholding PatternAs of FY26
Naspers Ventures B. V
11.58%
MacRitchie Investments Pte. Ltd
10.43%
TPG Growth V SF Markets Pte. Ltd
6.40%
Dr. Velumani A
5.70%
Evermed Holdings Pte. Ltd
5.64%
Others
60.25%

Key Managerial Personnel

As of FY26
NameDesignation and Experience
Dr. Dhaval Shah
Co-Founder
Siddharth Shah
Chief Executive Officer
Available now

Register to view prices and access exclusive investments.

Minimum ticket ₹10,000 - Start small. No large capital lock-in.
Reserve Access
or
Continue with Google
Reserve Access

FAQs on API Holdings (Pharmeasy) Unlisted Shares

What is the unlisted share price today?

unlisted share price is updated regularly on Precize. Visit Precize to check price movements and market trends.

How do I buy unlisted shares?

Register on Precize.in, complete KYC, select , enter quantity, and pay via UPI or NEFT. Shares are transferred within 24 hours.

What is 's revenue and profitability?

Please read these important legal notices and disclosures

None of the information displayed on or downloadable from https://www.precize.in represents an offer to buy or sell or a solicitation of an offer to buy or sell any security, nor does it constitute an offer to provide investment advice or service. Registered representatives of precize do not (1) Advise any member on the merits or advisability of a particular investment or transaction, or (2) Assist in the determination of fair value of any security or investment, or (3) Provide legal, tax, or transactional advisory services.

Read more

© 2026 Precize All Rights Reserved.

DECLARATION OF RISKTERMS OF USEPRIVACY POLICY
reported revenue of ₹6618.5 Cr in FYFY26. PAT was ₹N/A Cr. See full financials on this page.

What is the minimum investment for unlisted shares?

Minimum investment for unlisted shares starts from ₹10000. Please log in to view the latest pricing and availability